Loading...
Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...
Na minha lista:
| Udgivet i: | Dis Markers |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479487/ https://ncbi.nlm.nih.gov/pubmed/32934756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8855423 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|